US Stock Market Closed

Dashboard

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

S

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

About

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

CEO

Pascal Soriot

Employees

70,600

Industry

-

Sector

-

Headquarters

Cambridge

Exchange

New York Stock Exchange

Summary Stats

Market Cap

212B

Revenue

45.2B

Net Income

2.04B

EPS

$0.65

Price-to-Earnings

104.92

Price-to-Book

6.04

Debt-to-Equity

1.68

News

Analyst Ratings

Price targets projected by 22 analysts

High

$77.00

Average

$62.02

Low

$42.00

Ratings calculated by 26 analysts

Buy

18

Hold

5

Sell

3

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Above by $0.12

Actual

$0.84 +16.7%

Consensus

0.72

Report Date

Year Ago

0.54

Year Ago Change %

Up 55%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites